Newsletter Archive

  1. 10.15.26 -- The Orange Book's Blind Spot: Process Stability And Capability 10/15/2026

    10/15/26 Pharmaceutical Online Newsletter

  2. 10.15.26 -- Misconceptions And Metrics Of A Proactive CCS Strategy 10/15/2026

    10/15/26 Pharmaceutical Online Newsletter

  3. 10.14.26 -- New Advances In Drug Safety With Human-Relevant Preclinical Models 10/14/2026

    10/14/26 Pharmaceutical Online Newsletter

  4. 10.13.26 -- Why CMC Tech Transfer Should Begin With The End In Mind 10/13/2026

    10/13/26 Pharmaceutical Online Newsletter

  5. 10.12.26 -- Smarter Facility Design Starts With Better Process Control 10/12/2026
    10/12/26 Pharmaceutical Online Newsletter
  6. 10.10.26 -- Pharmaceutical Online Newsletter - Best Of September 10/10/2026

    10/10/26 Pharmaceutical Online Newsletter

  7. 10.09.26 -- Accelerate Pharma Innovation With Digital Solutions 10/9/2026
    10/09/26 Pharmaceutical Online Newsletter
  8. 10.09.26 -- ICH M4Q(R2) And M16 Modernize The CTD For Digital Submissions 10/9/2026

    10/09/26 Pharmaceutical Online Newsletter

  9. 10.08.26 -- What Does Digital CMC Maturity Look Like? 10/8/2026

    10/08/26 Pharmaceutical Online Newsletter

  10. 10.08.26 -- Engineering Better ADCs, Part 1: MoA, Conjugation Chemistry, And More 10/8/2026

    10/08/26 Pharmaceutical Online Newsletter